Patents by Inventor YACINE HAJJI

YACINE HAJJI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR NASH RISK ASSESSMENT IN PATIENTS HAVING A METABOLIC DISORDER
    Publication number: 20240282454
    Abstract: The present invention relates to a new assay to diagnose at-risk nonalcoholic steatohepatitis in patients with a metabolic disorder.
    Type: Application
    Filed: June 15, 2022
    Publication date: August 22, 2024
    Inventors: YACINE HAJJI, JÉRÉMY MAGNANENSI, CHRISTIAN ROSENQUIST, SUNEIL HOSMANE
  • METHODS OF DIAGNOSTIC OF LIVER FIBROSIS
    Publication number: 20240002939
    Abstract: The invention relates to a method for the identification of NAFLD patients likely to develop advanced liver fibrosis within 52 weeks.
    Type: Application
    Filed: October 29, 2021
    Publication date: January 4, 2024
    Inventors: SUNEIL HOSMANE, JÉRÉMY MAGNANENSI, YACINE HAJJI
  • METHOD FOR TREATMENT OF AT RISK PATIENTS
    Publication number: 20220241232
    Abstract: The invention provides an anti-fibrotic or anti-nonalcoholic steatohepatitis (NASH) drug for use in a method for reducing the risk for a subject to develop liver fibrosis or NASH, wherein the drug is administered to a subject classified as at risk to develop liver fibrosis or NASH. The invention further provides an anti-fibrotic or anti-NASH substance for use in a method for the treatment of liver fibrosis or NASH, wherein the drug is administered to a subject having type 2 diabetes.
    Type: Application
    Filed: June 8, 2020
    Publication date: August 4, 2022
    Inventors: JOHN BROZEK, NOÉMIE DAM, YACINE HAJJI, RÉMY HANF